Grants per year
- 175 - 200 out of 1,105 results
Search results
-
Research project
Prot #MM-141-07-02-02:A Randomized, Double-blind, Placebo-controlled Phase 2 Study of MM-141 plus Nab-paclitaxel and Gemcitabine versus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer
Mulcahy, M. F. & Nimeiri, H. S.
Clintrax Global, Inc., Merrimack Pharmaceuticals, Inc
5/22/15 → 5/22/18
Project: Research project
-
Prot# 378-ONC-0030-244: Phase I/II Study of Epirubicin and Celecoxib for Hepatocellular Carcinoma (NU Prot# NU 02I6)
9/22/02 → 7/31/04
Project: Research project
-
Prot# 20062040//NU0714: A Randomized Phase II Study of Dual Epidermal Growth Factor Receptor Inhibition with Erlotinib and Panitumumab With or Without Irinotecan as Second Line Therapy in Patients with Metastatic Colorectal Cancer
Benson III, A. B. & Mulcahy, M. F.
6/12/09 → 6/12/18
Project: Research project
-
Prot# AVF3537s / NU JH0711: Phase II Trial of Bevacizumab Combined with Transarterial Chemoembolization (TACE) for Hepatocellular Carcinoma
4/11/08 → 4/11/11
Project: Research project
-
Transcatheter Intra-Arterial Perfusion (TRIP) - MRI for Monitoring Liver Tumor Embolization
Larson, A. C., Lewandowski, R. J., Mulcahy, M. F. & Salem, R.
7/1/08 → 4/30/12
Project: Research project
-
Prot# SG040-0005: A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy (Rituximab, Ifosfamide, Carboplatin, and Etoposide) With and Without SGN-40 (anti-CD40 Humanized Monoclonal Antibody) for Second-Line Treatment of Patients with Diffus
PPD Development, Seattle Genetics, Inc.
12/1/07 → 12/1/10
Project: Research project
-
Prot# SG040-0004: A Phase II Study of SGN-40 (anti-huCD40 mAb) in Patients with Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)
4/27/07 → 12/1/11
Project: Research project
-
Prot# PXD101-301-G: A Phase II Clinical Trial of PXD101 In Patients with Advanced Multiple Myeloma
Prologue Research International, Inc., CuraGen Corporation
5/2/05 → 12/1/11
Project: Research project
-
Prot#2011-002: Carfilzomib Multiple Myeloma Expanded Access Protocol for Patients with Relapsed and Refractory Disease
ACT Oncology, LLC, Onyx Pharmaceuticals, Inc.
11/18/11 → 11/18/17
Project: Research project
-
Tissue-dynamics Imaging for Therapeutic Efficacy in Ovarian Cancer
Purdue University, National Institute of Biomedical Imaging and Bioengineering
1/1/16 → 4/30/18
Project: Research project
-
DRP 19: Generation of Genetically Altered Transforming Growth Factor beta Resistant CD-*+T-lymphocytes for Patients with Prostate Cancer
Lee, C., Zhang, Q. & Kuzel, T. M.
2/1/13 → 1/31/15
Project: Research project
-
NU UW16B13: A Phase II Study of Neratinib Alone and in Combination with Fulvestrant in Metastatic HER2 Non-amplified but HER2 Mutant Breast Cancer
Cristofanilli, M.
Washington University St. Louis, Puma Biotechnology, Inc.
5/1/17 → 5/1/20
Project: Research project
-
Non-Cancer Pain and Cognitive Impairment: A Disabling Relationship
National Palliative Care Research Center
7/1/08 → 6/30/10
Project: Research project